These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 32621769)

  • 1. Nail changes in upper extremity allotransplantation: onychomadesis as the presenting sign of allograft rejection - a retrospective study.
    Kanitakis J; Petruzzo P; Baran R; Gazarian A; Badet L; Morelon E
    Transpl Int; 2020 Oct; 33(10):1274-1281. PubMed ID: 32621769
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vascularized composite allotransplantation: current standards and novel approaches to prevent acute rejection and chronic allograft deterioration.
    Kueckelhaus M; Fischer S; Seyda M; Bueno EM; Aycart MA; Alhefzi M; ElKhal A; Pomahac B; Tullius SG
    Transpl Int; 2016 Jun; 29(6):655-62. PubMed ID: 26265179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Scabies in a bilateral hand allograft recipient: An additional mimicker of acute skin rejection in vascularized composite allotransplantation.
    Kanitakis J; Morelon E
    Transpl Infect Dis; 2017 Jun; 19(3):. PubMed ID: 28211139
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Defining chronic rejection in vascularized composite allotransplantation-The American Society of Reconstructive Transplantation and International Society of Vascularized Composite Allotransplantation chronic rejection working group: 2018 American Society of Reconstructive Transplantation meeting report and white paper Research goals in defining chronic rejection in vascularized composite allotransplantation.
    Kaufman CL; Kanitakis J; Weissenbacher A; Brandacher G; Mehra MR; Amer H; Zelger BG; Zelger B; Pomahac B; McDiarmid S; Cendales L; Morelon E
    SAGE Open Med; 2020; 8():2050312120940421. PubMed ID: 32704373
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is Skin the Most Allogenic Tissue in Vascularized Composite Allotransplantation and a Valid Monitor of the Deeper Tissues?
    Robbins NL; Wordsworth MJ; Parida BK; Kaplan B; Gorantla VS; Weitzel EK; Breidenbach WC
    Plast Reconstr Surg; 2019 Apr; 143(4):880e-886e. PubMed ID: 30921156
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Significance of Vascular Alterations in Acute and Chronic Rejection for Vascularized Composite Allotransplantation.
    Kollar B; Kamat P; Klein HJ; Waldner M; Schweizer R; Plock JA
    J Vasc Res; 2019; 56(4):163-180. PubMed ID: 31266018
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trauma-induced Rejection in Vascularized Composite Allotransplantation.
    Etra JW; Shores JT; Sander IB; Brandacher G; Lee WPA
    Ann Surg; 2020 May; 271(5):e113-e114. PubMed ID: 31090564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vascularized Composite Allotransplantation in Burn Reconstruction: Systematic Review and Meta-analysis.
    Gray KM; Peterson JM; Padilla PL; Smith JM; Zapata-Sirvent RL; Branski LK; Norbury WB; Dziewulski P
    J Burn Care Res; 2021 May; 42(3):465-472. PubMed ID: 33091131
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Systematic Review of the Reported Complications Related to Facial and Upper Extremity Vascularized Composite Allotransplantation.
    Milek D; Reed LT; Echternacht SR; Shanmugarajah K; Cetrulo CL; Lellouch AG; Langstein HN; Leckenby JI
    J Surg Res; 2023 Jan; 281():164-175. PubMed ID: 36162189
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Onychomadesis Following Cutaneous Vasculitis.
    Damevska K; Gocev G; Pollozahani N; Nikolovska S; Neloska L
    Acta Dermatovenerol Croat; 2017 Apr; 25(1):77-79. PubMed ID: 28511755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Infections after upper extremity allotransplantation: a worldwide population cohort study, 1998-2017.
    Conrad A; Petruzzo P; Kanitakis J; Gazarian A; Badet L; Thaunat O; Vanhems P; Buron F; Morelon E; Sicard A;
    Transpl Int; 2019 Jul; 32(7):693-701. PubMed ID: 30633815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Graft vasculopathy in upper extremity allotransplantation: Results of a retrospective high-resolution ultrasonographic study.
    Petruzzo P; Luong S; Kanitakis J; Sardu C; Feugier P; Danjou F; Gazarian A; Badet L; Morelon E
    Clin Transplant; 2021 Jan; 35(1):e14130. PubMed ID: 33099801
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Graft vasculopathy of vascularized composite allografts in humans: a literature review and retrospective study.
    Ng ZY; Lellouch AG; Rosales IA; Geoghegan L; Gama AR; Colvin RB; Lantieri LA; Randolph MA; Cetrulo CL
    Transpl Int; 2019 Aug; 32(8):831-838. PubMed ID: 30829423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Upper extremity and craniofacial vascularized composite allotransplantation: ethics and immunosuppression.
    Benedict J; Magill G
    Emerg Top Life Sci; 2019 Nov; 3(6):681-686. PubMed ID: 32915212
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evolution of the rat hind limb transplant as an experimental model of vascularized composite allotransplantation: Approaches and advantages.
    Fleissig YY; Beare JE; LeBlanc AJ; Kaufman CL
    SAGE Open Med; 2020; 8():2050312120968721. PubMed ID: 33194200
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toward Development of the Delayed Tolerance Induction Protocol for Vascularized Composite Allografts in Nonhuman Primates.
    Lellouch AG; Ng ZY; Rosales IA; Schol IM; Leonard DA; Gama AR; Colvin RB; Lantieri LA; Randolph MA; Cetrulo CL
    Plast Reconstr Surg; 2020 Apr; 145(4):757e-768e. PubMed ID: 32221215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Noninvasive evaluation of intragraft immune responses in upper extremity transplantation.
    Messner F; Etra JW; Shores JT; Thoburn CJ; Hackl H; Iglesias Lozano M; Fidder SAJ; Guo Y; Kambarashvili K; Alagol K; Kalsi R; Beck SE; Cooney C; Furtmüller GJ; Krapf J; Oh BC; Brandacher G
    Transpl Int; 2021 May; 34(5):894-905. PubMed ID: 33626223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MMP3 Is a Non-invasive Biomarker of Rejection in Skin-Bearing Vascularized Composite Allotransplantation: A Multicenter Validation Study.
    Kollar B; Uffing A; Borges TJ; Shubin AV; Aoyama BT; Dagot C; Haug V; Kauke M; Safi AF; Talbot SG; Morelon E; Dakpe S; Pomahac B; Riella LV
    Front Immunol; 2019; 10():2771. PubMed ID: 31849957
    [No Abstract]   [Full Text] [Related]  

  • 19. MicroRNAs in solid organ and vascularized composite allotransplantation: Potential biomarkers for diagnosis and therapeutic use.
    Di Stefano AB; Pappalardo M; Moschella F; Cordova A; Toia F
    Transplant Rev (Orlando); 2020 Oct; 34(4):100566. PubMed ID: 32682704
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Provider Perspective of Psychosocial Predictors of Upper-Extremity Vascularized Composite Allotransplantation Success.
    Kinsley SE; Williams EE; Lenhard NK; Shah SB; Edwards RR; Katz JN; Talbot SG
    J Hand Surg Am; 2022 Apr; 47(4):387.e1-387.e19. PubMed ID: 34266683
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.